You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
Science delves further into what other researchers knew about CRISPR scientist He Jiankui's plans, including his early-stage ideas for a clinic.
The Broad Institute called UC's new legal strategy "deeply unfortunate" and called on the university to "move beyond litigation."
As MPEG LA tries to complete its larger CRISPR IP patent pool, smaller license agreements continue and a mini-pool has emerged between key players.
Researchers sequenced edits made at 1,656 on-target genomic sites in primary human T cells and used the data to train the model.
The first trial using CRISPR within the human body is to begin this fall to treat a form of blindness.
Researchers developed a system for continuous evolution of base editors, which should continue to improve their functionality.
A New Zealand minister says the country's genetic modification laws need to be re-examined to help combat climate change, the New Zealand Herald reports.
A new report says genetically modified food might be necessary to be able to feed a planet of nearly 10 billion people, Bloomberg says.
The Broad will now offer licenses for both its own CRISPR IP and MilliporeSigma's to companies using CRISPR in their research and development activities.
A Russian researcher says he plans to edit the genomes of embryos from deaf couples, New Scientist reports.
Following discrimination allegations, NICHD's Constantine Stratakis withdraws from a new position at the Research Institute of the McGill University Health Center, Science reports.
US President Donald Trump has threatened to cut World Health Organization funding over its pandemic response, which would affect its ability to do its work and which he might not be able to do.
The US Securities and Exchange Commission has halted the sales of a handful of stocks over claims made about the coronavirus.
In Nature this week: comparative analyses of single-cell RNA sequencing protocols uncover differences between approaches, and more.